Femasys (FEMY) FCF Margin (2020 - 2026)
Femasys' (FEMY) quarterly FCF Margin came in at 1188.9% in Q2 2026, down 10233.0% on a YoY basis from N/an in Q2 2025, and down 9.42% quarter-over-quarter from 1086.57% in Q2 2025.
Powered by 
Analysis
Femasys (FEMY) FCF Margin (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported FCF Margin for 7 consecutive years, with 1188.9% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 10233.0% year-over-year to 1188.9%; the trailing twelve-month figure through Jun 2026 stood at 1086.25% (down 662.0% YoY), and the FY2025 full-year result was 837.9%, up 40240.0% from the prior year.
- FCF Margin declined to 1188.9% in Q2 2026 per FEMY's latest filing, from 1086.57% in the prior quarter.
- Across five years, FCF Margin topped out at 791.1% in Q3 2022 and bottomed at 2035.85% in Q2 2024.
- Historically, FCF Margin has averaged 1172.81% across 5 years, with a median of 1086.57% in 2025.
- The sharpest annual moves came in 2024 and 2025: FCF Margin slumped 116096 bps in 2024, then jumped 94928 bps in 2025.
- Over 5 years, FCF Margin stood at 1264.39% in 2022, then dropped by 14 bps to 1445.67% in 2023, then surged by 38 bps to 890.92% in 2024, then decreased by 22 bps to 1086.57% in 2025, then slipped by 9 bps to 1188.9% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 1188.9%, 1086.57%, and 1424.65% for Q2 2026, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 18.73% |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | -1,188.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,188.90% |
| Jun 30, 2025 | -1,086.57% |
| Mar 31, 2025 | -1,424.65% |
| Dec 31, 2024 | -890.92% |
| Sep 30, 2024 | -1,060.10% |
| Jun 30, 2024 | -2,035.85% |
| Mar 31, 2024 | -1,708.59% |
| Dec 31, 2023 | -1,445.67% |
| Sep 30, 2023 | -1,179.78% |
| Jun 30, 2023 | -874.89% |
| Mar 31, 2023 | -903.63% |
| Dec 31, 2022 | -1,264.39% |
| Sep 30, 2022 | -791.10% |
| Jun 30, 2022 | -842.78% |
| Mar 31, 2022 | -894.32% |
| Dec 31, 2021 | -930.50% |
| Sep 30, 2021 | -733.45% |
| Jun 30, 2021 | -838.39% |
| Mar 31, 2021 | -351.96% |
| Dec 31, 2020 | -452.37% |